“…Later, two more HCoVs were identified, HCoV‐NL63 in 2004 and HCoV‐HKU1 the following year (Van Der Hoek et al., 2004; Woo et al., 2005). Of these five HCoVs, SARS‐CoV was the only highly pathogenic HCoV until the emergence of Middle East respiratory syndrome coronavirus (MERS‐CoV) in 2012 and then SARS‐CoV‐2, the causative agent of coronavirus disease 2019 (COVID‐19), in late 2019 (Li et al., 2021; Otter et al., 2023). Unlike SARS‐CoV, MERS‐CoV, and SARS‐CoV‐2, which are associated with severe respiratory disease, HCoV‐229E, ‐OC43, ‐NL63, and ‐HKU1 generally cause mild to moderate upper‐respiratory‐tract disease, though they can also cause more severe disease in at‐risk populations, such as the elderly, the immunocompromised, and young children (Liu et al., 2020).…”